This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Jul 19;372(9634):185-6.

doi: 10.1016/S0140-6736(08)61050-8.

Apolipoprotein B/A1 and risk of cardiovascular disease

Lars Lind¹

Affiliations

PMID: 18640440
DOI: 10.1016/S0140-6736(08)61050-8

Comment

Apolipoprotein B/A1 and risk of cardiovascular disease

Lars Lind. Lancet. 2008.

. 2008 Jul 19;372(9634):185-6.

doi: 10.1016/S0140-6736(08)61050-8.

Author

Lars Lind¹

Affiliation

¹ Department of Medicine, University Hospital, 75185 Uppsala, Sweden.

PMID: 18640440
DOI: 10.1016/S0140-6736(08)61050-8

No abstract available

PubMed Disclaimer

Comment on

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.
McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S; INTERHEART study investigators. McQueen MJ, et al. Lancet. 2008 Jul 19;372(9634):224-33. doi: 10.1016/S0140-6736(08)61076-4. Lancet. 2008. PMID: 18640459

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information